Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma Colorectal cancer (CRC) remains a major global health burden, being ...

Antibody-drug conjugates (ADCs) have reshaped the cancer treatment landscape across a variety of different tumor types. ADCs' peculiar pharmacologic design combines the cytotoxic properties of ...

Antigen-driven TCR signaling in the epidermis during CD8+ TRM differentiation results in a lower TGFβ requirement for persistence and increased proliferative capacity that together enhance epidermal ...

A new study by LMU and Helmholtz Munich shows how pathogens control changes in their cell surface to evade the immune system. The immune system responds to an infection by producing antibodies that ...

Antigen tests can identify the presence of antigens within the body, which are substances that cause immune responses, such as the release of antibodies. The immune system, and antibodies specifically ...

Researchers have created a highly detailed spatial multiomic atlas to date of glioma tumour microenvironments.